Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Quoted Innovation Digital Health

QUOTED. 11 July 2019. Ranndy Kellogg.

  • Analysis

Executive Summary

This year, Omron Healthcare introduced its new HeartGuide smartwatch and the first US FDA-cleared blood pressure monitor with EKG capability, Complete, which it developed in partnership with AliveCor. See what Omron's CEO, Ranndy Kellogg, said about the company's plans here.

"We are in the process of developing a road map [for the next five years] of which features to add. There are lots of different data points we can collect via that device." – Ranndy Kellogg, CEO, Omron Healthcare

Click here for a free trial of Medtech Insight
Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Quoted Innovation Digital Health
Latest Headlines

Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

See All
UsernamePublicRestriction

Register

MT125353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By